Health Product InfoWatch, May 2026
Content: Safety brief: Diosmin or diosmin in combination with hesperidin; Lunsumio / Lunsumio SC: Authorization with conditions
Monthly update to the Canada Vigilance adverse reaction online database
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to January 31, 2026. The next update of data is scheduled for early June 2026.
Health Promotion and Chronic Disease Prevention in Canada, Vol 46, No 5, May 2026
Systemic and organizational barriers to primary chronic disease prevention: a qualitative study of public health organizations in Canada; Misclassification bias in chronic disease case ascertainment algorithms: a reclassification approach
Monthly update to the list of new safety and effectiveness reviews for health products
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between March 1 and 31, 2026. The next update is scheduled for June 2026.
Health Product InfoWatch, April 2026
Safety brief: Falsely elevated digoxin levels; Product monograph update: Taro-Melphalan
Health Product InfoWatch, April 2026
Safety brief: Falsely elevated digoxin levels; Product monograph update: Taro-Melphalan
Monthly update to the Canada Vigilance adverse reaction online database
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to December 31, 2025. The next update of data is scheduled for early May, 2026.